T Cells as an Emerging Target for Chronic Pain Therapy
Open Access
- 11 September 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 12, 216
Abstract
The immune system is critically involved in the development and maintenance of chronic pain. However, T cells, one of the main regulators of the immune response, have only recently become a focus of investigations on chronic pain pathophysiology. Emerging clinical data suggest that patients with chronic pain have a different phenotypic profile of circulating T cells compared to controls. At the preclinical level, findings on the function of T cells are mixed and differ between nerve injury, chemotherapy, and inflammatory models of persistent pain. Depending on the type of injury, the subset of T cells and the sex of the animal, T cells may contribute to the onset and/or the resolution of pain, underlining T cells as a major player in the transition from acute to chronic pain. Specific T cell subsets release mediators such as cytokines and endogenous opioid peptides that can promote, suppress, or even resolve pain. Inhibiting the pain-promoting functions of T cells and/or enhancing the beneficial effects of pro-resolution T cells may offer new disease-modifying strategies for the treatment of chronic pain, a critical need in view of the current opioid crisis.Keywords
This publication has 155 references indexed in Scilit:
- ifn-γ-dependent secretion of IL-10 from Th1 cells and microglia/macrophages contributes to functional recovery after spinal cord injuryCell Death & Disease, 2013
- Sympathectomy attenuates excitability of dorsal root ganglion neurons and pain behaviour in a lumbar radiculopathy modelBone & Joint Research, 2012
- Systematic review with meta-analysis: cytokines in fibromyalgia syndromeBMC Musculoskeletal Disorders, 2011
- Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAEJournal of Experimental Medicine, 2011
- IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotectionBrain, Behavior, and Immunity, 2011
- Autoantibodies to the δ-opioid receptor function as opioid agonists and display immunomodulatory activityJournal of Neuroimmunology, 2009
- Matrix metalloprotease regulation of neuropathic painTrends in Pharmacological Sciences, 2009
- Immune cell–derived opioids protect against neuropathic pain in miceJournal of Clinical Investigation, 2009
- CD4 T cells: fates, functions, and faultsBlood, 2008
- CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic painEuropean Journal of Immunology, 2008